Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Consensus report: faecal microbiota transfer – clinical applications and procedures
Julia König, Arno Siebenhaar, Christoph Högenauer, et al.
Alimentary Pharmacology & Therapeutics (2016) Vol. 45, Iss. 2, pp. 222-239
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
Christopher A Lamb, Nicholas A. Kennedy, Tim Raine, et al.
Gut (2019) Vol. 68, Iss. Suppl 3, pp. s1-s106
Open Access | Times Cited: 1861
Recovery of gut microbiota of healthy adults following antibiotic exposure
Albert Pallejá, Stine Ulrik Mikkelsen, Sofia K. Forslund, et al.
Nature Microbiology (2018) Vol. 3, Iss. 11, pp. 1255-1265
Closed Access | Times Cited: 649
Systematic review with meta‐analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection
Mohammed Nabil Quraishi, Monika Widłak, Neeraj Bhala, et al.
Alimentary Pharmacology & Therapeutics (2017) Vol. 46, Iss. 5, pp. 479-493
Open Access | Times Cited: 530
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Sudarshan Paramsothy, Ramesh Paramsothy, David T. Rubin, et al.
Journal of Crohn s and Colitis (2017) Vol. 11, Iss. 10, pp. 1180-1199
Open Access | Times Cited: 385
The role of the microbiome for human health: from basic science to clinical applications
M. Hasan Mohajeri, Robert J. Brummer, Robert A. Rastall, et al.
European Journal of Nutrition (2018) Vol. 57, Iss. S1, pp. 1-14
Open Access | Times Cited: 380
The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridium difficileinfection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Benjamin H. Mullish, Mohammed Nabil Quraishi, Jonathan Segal, et al.
Gut (2018) Vol. 67, Iss. 11, pp. 1920-1941
Open Access | Times Cited: 304
Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening
Ting Zhang, Gaochen Lu, Zhe Zhao, et al.
Protein & Cell (2020) Vol. 11, Iss. 4, pp. 251-266
Open Access | Times Cited: 202
Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease
Charlotte Woodhouse, Vishal Patel, Arjuna Singanayagam, et al.
Alimentary Pharmacology & Therapeutics (2017) Vol. 47, Iss. 2, pp. 192-202
Open Access | Times Cited: 179
ESPEN guideline on Clinical Nutrition in inflammatory bowel disease
Stephan C. Bischoff, Palle Bager, Johanna C. Escher, et al.
Clinical Nutrition (2023) Vol. 42, Iss. 3, pp. 352-379
Open Access | Times Cited: 178
The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis
Patrizia Kump, Philipp Wurm, H Gröchenig, et al.
Alimentary Pharmacology & Therapeutics (2017) Vol. 47, Iss. 1, pp. 67-77
Open Access | Times Cited: 174
You’ve got male: Sex and the microbiota-gut-brain axis across the lifespan
Minal Jaggar, Kieran Rea, Simon Spichak, et al.
Frontiers in Neuroendocrinology (2019) Vol. 56, pp. 100815-100815
Open Access | Times Cited: 158
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractoryClostridium difficileinfection-single versus multiple infusions
Gianluca Ianiro, Luca Masucci, Gianluca Quaranta, et al.
Alimentary Pharmacology & Therapeutics (2018) Vol. 48, Iss. 2, pp. 152-159
Open Access | Times Cited: 139
Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes?
Judith Aron‐Wisnewsky, Karine Clément, Max Nieuwdorp
Current Diabetes Reports (2019) Vol. 19, Iss. 8
Open Access | Times Cited: 125
Systematic review with meta‐analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation
Cheuk Yin Lai, Joanne Sung, Felix Cheng, et al.
Alimentary Pharmacology & Therapeutics (2019) Vol. 49, Iss. 4, pp. 354-363
Open Access | Times Cited: 105
A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group
Josbert J. Keller, Rogier E. Ooijevaar, Christian Lodberg Hvas, et al.
United European Gastroenterology Journal (2020) Vol. 9, Iss. 2, pp. 229-247
Open Access | Times Cited: 105
Healthy hosts rule within: ecological forces shaping the gut microbiota
Mariana X. Byndloss, Sandy R. Pernitzsch, Andreas J. Bäumler
Mucosal Immunology (2018) Vol. 11, Iss. 5, pp. 1299-1305
Open Access | Times Cited: 97
Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis
Luciane de Fátima Caldeira, Helena Hiemisch Lobo Borba, Fernanda S. Tonin, et al.
PLoS ONE (2020) Vol. 15, Iss. 9, pp. e0238910-e0238910
Open Access | Times Cited: 90
The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study
Savanne Holster, C. Lindqvist, Dirk Repsilber, et al.
Clinical and Translational Gastroenterology (2019) Vol. 10, Iss. 4, pp. e00034-e00034
Open Access | Times Cited: 89
The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome
Yu Gu, Guoqiong Zhou, Xiali Qin, et al.
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 76
Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis
Sofie Ingdam Halkjær, Bobby Lo, Frederik Cold, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 20, pp. 3185-3202
Open Access | Times Cited: 24
Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome
Lucinda A. Harris, Noemi Baffy
Postgraduate Medicine (2017) Vol. 129, Iss. 8, pp. 872-888
Open Access | Times Cited: 79
Cutting Edge: Probiotics and Fecal Microbiota Transplantation in Immunomodulation
Wenjie Zeng, Jie Shen, Tao Bo, et al.
Journal of Immunology Research (2019) Vol. 2019, pp. 1-17
Open Access | Times Cited: 67
Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta‐analysis
Kanchana Myneedu, Abhizith Deoker, Max J. Schmulson, et al.
United European Gastroenterology Journal (2019) Vol. 7, Iss. 8, pp. 1033-1041
Open Access | Times Cited: 67
From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation
Carole Nicco, Armelle Paule, Peter C. Konturek, et al.
Diseases (2020) Vol. 8, Iss. 2, pp. 9-9
Open Access | Times Cited: 61
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Benjamin H. Mullish, Mohammed Nabil Quraishi, Jonathan Segal, et al.
Journal of Hospital Infection (2018) Vol. 100, pp. S1-S31
Open Access | Times Cited: 59
Page 1 - Next Page

Scroll to top